Desaspidin

This classification denotes an antihelminthic agent with the molecular formula C24H30O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KV3495SGKS, chemically known as 3-((5-butyryl-2,4-dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadien-1-yl)methyl)-2,6-dihydroxy-4-methoxybutyrophenone but generally known as desaspidin, which bears US NIH Compound Identifier 8238. European Medicines Agency schedules Desaspidin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06989MIG. The term DESASPIDIN BB is an International Non-Proprietary Name. World Health Organization schedules desaspidin in its Anatomical Therapeutic Chemical (ATC) Classification. DESASPIDIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule desaspidin under HS 29145000 and SITC 51629. As of Q4 2014, DESASPIDIN remains the US FDA Preferred Term for this commodity. Desaspidin bears US NLM identifiers UMLS ID C0057515 and NCI Concept Code C81515. SMILES: OC1=C(CC2C(O)C(C(O)CC2OC)C(=O)CCC)C(=C(C(=O)C1(C)C)C(=O)CCC)O.